Cochlear Combines With Sensorion To Explore Hearing-Loss Treatments

Cochlear Ltd. has formed an alliance with French biotech company Sensorion to explore if a combination drug/hearing implant can improve the treatment of hearing loss. The collaboration moves Cochlear outside of its device field and could see it obtain a global license for Sensorion's SENS-401 drug candidate.